Ossiform
Thea Wulff Olesen
Group CEO

Ossiform® is a British-Danish MedTech company that is forming a new generation of structural bioactive bone substitutes with a mission to reduce complications, improve functional outcomes, and accelerate recovery. We are continuously working to redefine bone replacements through progressive research and close collaboration with physicians and industry partners. Our patient-centric approach and commitment to innovation, quality, and progress steer our efforts to provide best-in-class implant solutions that facilitate the natural forming of new bone.​